Popular hair loss drug linked to higher suicide risk
Finasteride users face higher suicide risk, new study finds.
Why it matters
- Finasteride, used for hair loss, is linked to higher risks of depression, anxiety, and suicidal thoughts.
- The study combines findings from multiple research studies, highlighting a significant mental health concern.
- Raises questions about the regulation and safety of cosmetic drugs.
By the numbers
- Over 30 years, 19,320 suicides were expected among users.
- By 2024, 320 suicides were reported.
- Expected suicidal thoughts: 414,000; reported by 2024: 1,062.
The big picture
- Finasteride affects brain chemicals, potentially causing lasting changes and mental health issues.
- Underreporting of side effects is a major concern due to various factors.
- Calls for better post-marketing studies and stricter regulation of cosmetic drugs.
What they're saying
- Users share personal anecdotes and concerns about the drug's effects.
- Questions raised about the study's control for pre-existing conditions like depression due to hair loss.
- General awareness of depressive side effects among users.
Caveats
- The study is a review, which may have inherent limitations.
- Underreporting of side effects could skew the data.
- Systemic failures in pharmacovigilance are noted.
What’s next
- More rigorous post-marketing studies are needed.
- Better regulation and monitoring of cosmetic drugs like finasteride.